Covaxin

Bharat Biotech Partners With US University For Single-Dose Covid Vaccine

India News | Written by Uma Sudhir | Thursday September 24, 2020

Hyderabad-based pharma firm Bharat Biotech, which is developing coronavirus vaccine COVAXIN, has signed a licensing deal with Washington University School of Medicine in Missouri's St. Louis, United States, for a "novel chimp-adenovirus", single dose intranasal vaccine for COVID-19. Bharat Biotech would be allowed to distribute the vaccine in all m...

Over 57 Lakh Covid-19 Cases In India, 86,508 Fresh Cases; 1,129 Deaths

India News | Edited by Nandini Gupta | Thursday September 24, 2020

India reported 86,508 new Covid cases in the past 24 hours taking its coronavirus tally past the 57-lakh mark, shows the Health Ministry's COVID-19 data; the country reported 1,129 deaths in this period. With 87,374 more people having beaten COVID-19, the number of total recoveries remained higher than the number of new infections for the sixth con...

UP Government Allows Trial Of COVID-19 Vaccine "Covaxin" In Lucknow, Gorakhpur

India News | Press Trust of India | Thursday September 24, 2020

The Uttar Pradesh Government on Wednesday allowed the phase-3 trial of anti-COVID-19 vaccine "Covaxin" in Lucknow and Gorakhpur.

"Robust Immune Responses": Indian Vaccine-Maker After Test On Monkeys

India News | Reported by Sukirti Dwivedi, Edited by Debanish Achom | Saturday September 12, 2020

Bharat Biotech that is developing the coronavirus vaccine COVAXIN in its latest report has said an animal study has shown a vaccine candidate has helped develop a strong immune response to the highly infectious coronavirus.

In Odisha, Preparation On For 2nd Phase Of Human Clinical Trial Of Covid Vaccine

India News | Press Trust India | Monday August 31, 2020

Preparations are underway at a hospital in Bhubaneswar for the commencement of the second phase of human clinical trial of "Covaxin", India's indigenous COVID-19 vaccine, officials said.

Russia Rejects Safety Concerns; Medics To Get Anti-Covid Shots In 2 Weeks

World News | Reuters | Wednesday August 12, 2020

Russian Health Minister Mikhail Murashko said on Wednesday allegations that Russia's COVID-19 vaccine was unsafe were groundless and driven by competition, the Interfax news agency reported.

Human Clinical Trial Of COVID-19 Vaccine "Covaxin" Begins At UP Hospital

India News | Press Trust of India | Friday July 31, 2020

The human clinical trial of indigenously developed Covaxin, a possible vaccine against coronavirus, began at a hospital here, officials said on Friday.

Human Trial Of "Covaxin" Begins At SUM Hospital In Bhubaneswar

India News | ANI | Tuesday July 28, 2020

The human trial of India's first indigenous vaccine candidate "Covaxin" began at the Institute of Medical Sciences and SUM Hospital in Bhubaneswar on Monday.

Human Clinical Trial Of Covid Vaccine "Covaxin" Begins At Odisha Hospital

India News | Press Trust of India | Monday July 27, 2020

The human clinical trial of indigenously developed Covaxin, a possible vaccine against the novel coronavirus, began at an institute here on Monday, a senior official said.

Man, 30, Gets First Dose Of India's Covid Vaccine As Human Trial Begins

India News | Reported By Parimal Kumar, Edited By Abhinav Bhatt | Sunday July 26, 2020

A 30-year-old man was on Friday given the first dose of undertrial coronavirus vaccine named as COVAXIN in Delhi's All India Institute Of Medical Sciences.

Man Receives First Dose Of Covaxin In Phase-I Of Human Trial At Delhi AIIMS

India News | Press Trust of India | Saturday July 25, 2020

The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at Delhi AIIMS on Friday and the first dose of the injection was administered to a man who is in his 30s.

Covaxin Human Trials: Delhi's Dr Dangs Lab To Partner With Bharat Biotech

India News | Press Trust of India | Thursday July 23, 2020

A Delhi-based private laboratory, Dr Dangs Lab, has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with ICMR and NIV, Pune.

Covaxin Human Trials: Delhi's Dr Dangs Lab To Partner With Bharat Biotech

India News | Press Trust of India | Thursday July 23, 2020

A Delhi-based private laboratory, Dr Dangs Lab, has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with ICMR and NIV, Pune.

Coronavirus Vaccine Human Trial Begins, Result In 3 Months: AIIMS Head

India News | Reported by Sukirti Dwivedi, Edited by Nandini Gupta | Monday July 20, 2020

The human trials of the indigenously developed coronavirus vaccine, COVAXIN, began today, AIIMS-Delhi Director Dr Randeep Guleria said, adding that it would take at least three months for researchers to arrive at the first set of data.

AIIMS Panel Allows Human Trial Of India's First Coronavirus Vaccine

India News | Press Trust of India | Sunday July 19, 2020

The AIIMS Ethics Committee on Saturday gave its nod for a human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin following which the premier hospital is likely to begin the exercise by enrolling healthy volunteers from Monday.